Another recent study found that KRAS-driven lung adenocarcinoma tumor samples have dramatically increased cell size, but did not examine the effects of KRAS in the absence of additional passenger mutations present in tumor cells(Sandlin et al., 2022). This evidence concerns the gene KRAS and lung adenocarcinoma.